2B Capital SA agreed to acquire 34.8% of the shares of the hematology service provider and clinical laboratory Hemoterapia Brasil SA (H. Hemo), for an amount not disclosed.
2B Capital SA agreed to acquire 34.8% of the shares of the hematology service provider and clinical laboratory Hemoterapia Brasil SA (H. Hemo), for an amount not disclosed.